Mondaq Australia: Intellectual Property > Patent
Shelston IP
Searching prior art (everything known and published in the field at the time) is essential when developing inventions.
Shelston IP
Designed for commuters, the Brompton folding bike is protected by several internationally registered trade marks.
ClarkeKann Lawyers
A shareholders agreement is a key cornerstone for protecting and ultimately realising the value of an IP-based business.
Shelston IP
This article outlines the main types of claims pursued when drafting a patent application in the chemical sciences field.
Dennemeyer Group
Before answering this fundamental question, one needs to understand what is meant by disruption.
Norton Rose Fulbright Australia
This article discusses some of the key provisions of the new Act and how they will affect Australia's existing IP regime.
Shelston IP
Discusses the unitary patent and Unified Patent Court, current issues and the significance of the timing of German ratification.
Davies Collison Cave
On 20 August 2018, the Australian Patent Office gave Apple Inc. another chance to patent a fancy way of displaying time on iPad, iPhone and Apple Watch devices.
Davies Collison Cave
In a much welcomed sign for researchers, companies and investors alike in the field of nucleic acid-based therapeutics, on 10 August 2018 the US Food and Drug Administration (FDA) approved
Shelston IP
Whether the failure of this Bill influences the future of the Innovation patent system in Australia remains to be seen.
Davies Collison Cave
In April 2018, the Australian Patent Office held the hearing of BGC Partners Inc [2018] APO 27, in which it refused a patent application in the area of financial trading for failing to claim patentable subject matter.
Shelston IP
It may be mere coincidence that second-tier patents regimes were considered simultaneously in Australia and New Zealand,.
Corrs Chambers Westgarth
This judgment does provide some clarity on the issue of anti-competitive purpose, for pharmaceutical patent owners.
Shelston IP
These proposed changes will impact on how Australia capitalises on its innovation strategy and competitive position.
Shelston IP
This article discusses some useful tips on how to read and understand prior art patent literature more efficiently.
Shelston IP
This article outlines main stages of the innovation process, relevant IP tools and intellectual asset advisory services.
Shelston IP
The parallels between NZ's proposed Advancement patent and Australia's current Innovation patent are readily apparent.
Shelston IP
Investors financing eligible Early Stage Innovation Companies may be entitled to tax concessions and CGT exemptions.
Jones Day
Rituximab is sold by Roche under the brand name "MabThera". Sandoz registered its rituximab biosimilar, "Riximyo", on the Australian Register of Therapeutic Goods in November 2017 for the same indications as MabThera, including the patented indications.
Madderns Patent & Trade Mark Attorneys
Bluescope Steel has engaged in a long running battle with IP Australia to protect branding on a pre-painted steel strip.
Most Popular Recent Articles
Norton Rose Fulbright Australia
A branding strategy is a long term plan for the development of successful product marketing through brand awareness.
Norton Rose Fulbright Australia
A wide variety of grants and funding programs can assist start-ups and businesses develop and commercialise their IP.
Norton Rose Fulbright Australia
This article discusses some of the key provisions of the new Act and how they will affect Australia's existing IP regime.
Dennemeyer Group
Before answering this fundamental question, one needs to understand what is meant by disruption.
Davies Collison Cave
On 20 August 2018, the Australian Patent Office gave Apple Inc. another chance to patent a fancy way of displaying time on iPad, iPhone and Apple Watch devices.
Shelston IP
This article outlines the main types of claims pursued when drafting a patent application in the chemical sciences field.
Davies Collison Cave
In Encompass Corporation Pty Ltd v InfoTrack Pty Ltd [2018] FCA 421, Justice Perram of the Federal Court of Australia found two innovation patents to be invalid for not involving a manner of manufacture...
Shelston IP
Discusses the unitary patent and Unified Patent Court, current issues and the significance of the timing of German ratification.
Clayton Utz
The phase-out of Australia's innovation patents system is gradual, and innovation patents will be in force until 2027.
Jones Day
The Situation: Pfizer, a pharmaceutical manufacturer, brought an application for preliminary discovery of certain confidential documents belonging to Samsung Bioepis ("SB") ...
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter